Median Technologies to Present at TD Cowen 46th Annual Health Care Conference

Estimated Read Time: 3 minutes

Median Technologies, a developer of artificial intelligence-powered imaging solutions for oncology and early cancer diagnosis, has announced its participation in the TD Cowen 46th Annual Health Care Conference taking place from March 2–4, 2026, in Boston, Massachusetts.

The annual healthcare event brings together industry executives, investors, and analysts to discuss innovation trends, clinical advancements, and investment opportunities shaping the global healthcare sector.

Executive Presentation Scheduled

Fredrik Brag, Founder and Chief Executive Officer of Median Technologies, is scheduled to present company updates and upcoming strategic milestones on March 4, 2026. The presentation will highlight progress across the company’s artificial intelligence-driven medical imaging portfolio and ongoing commercialization initiatives.

A live webcast of the session will be accessible through the company’s investor relations website, with a replay available following the event for registered participants.

Advancing AI-Based Cancer Diagnostics

Median Technologies focuses on developing Software as a Medical Device (SaMD) solutions designed to enhance early cancer detection and treatment decision-making. Its AI-powered platforms support pharmaceutical companies and healthcare providers by improving imaging analysis accuracy and accelerating clinical research workflows.

The company’s technology portfolio includes advanced imaging services for oncology trials as well as AI-based diagnostic software aimed at enabling earlier and more precise disease identification.

Strengthening Investor Engagement

Participation in the TD Cowen Health Care Conference provides Median Technologies with an opportunity to engage directly with investors and industry stakeholders while outlining its growth strategy and innovation roadmap.

The conference features presentations, panel discussions, and fireside conversations led by healthcare and capital markets experts focusing on emerging medical technologies and sector investment trends.

About Median Technologies

Headquartered in Sophia Antipolis, France, Median Technologies delivers AI-powered imaging analysis and digital health solutions supporting oncology drug development and clinical diagnostics worldwide. The company operates across Europe, the United States, and Asia, helping advance precision medicine through data-driven medical innovation.

Additional company updates and investor materials are available on the Median Technologies Investor Relations page.